Transplantation of HCV-positive Organs into HCV-negative Recipients

Feb 06 2:00 PM - Feb 06, 3:00 PM 2018
Feb 06, 2018 2:00 PM - 3:00 PM

Purpose: Hundreds of high-quality organs from HCV-positive donors are ruled out or discarded annually. Transplanting these organs into HCVnegative recipients is a feasible way to optimize organ utilization, as anti-HCV therapy is now effective in the post-transplant setting. Recent data confirm the safety of transplanting HCV-positive organs into HCV-negative recipients, who then undergo anti-HCV therapy; moreover, reported transplant outcomes are excellent. Experience has been gained in both abdominal and thoracic transplant recipients. These data will be presented in detail by Dr. David Goldberg, a national thought-leader on this topic and one of the pioneers of this strategy.

Objectives: At the end of the webinar, participants should be able to:

  • Identify the number of organs discarded annually due to HCV infection in deceased donors.
  •  Discuss the effectiveness of anti-HCV therapy in the post-transplant setting.
  • Summarize outcomes associated with transplanting HCV-positive organs into HCV-negative recipients.